LL-37 vs Thymosin Alpha-1.
Side-by-side research comparison of LL-37 and Thymosin Alpha-1: dosing, half-life, side effects, and mechanism of action.
Quick Verdict
LL-37 for direct antimicrobial action — destroys biofilms and pathogens on contact. Thymosin Alpha-1 for immune system calibration — trains T-cells to mount better responses. Use LL-37 to kill the infection; use TA1 to strengthen your immune system against future threats.
Side-by-Side Analysis
| Dimension | LL-37 | Thymosin Alpha-1 |
|---|---|---|
| Mechanism | The only human cathelicidin antimicrobial peptide. | Enhances T-cell function, boosts dendritic cell activity, and modulates cytokine production. |
| Primary Benefits | Broad-spectrum antimicrobial, anti-biofilm, wound healing, immune modulation, anti-inflammatory | Immune support, antiviral, recovery |
| Typical Dose | 100–100mcg | 1500–1500mcg |
| Route | SubQ | SubQ |
| Frequency | 7x/wk | 2x/wk |
| Half-Life | 4 hours | 2 hours |
| FDA Status | Approved | Approved |
| Evidence Grade | moderate | moderate-strong |
| Key Studies | 20+ indexed | 20+ indexed |
| Lowest Price | $94.97 / 5mg via Bio Longevity Labs | $78.00 / 10mg via Ascension Peptides |
Which one should you choose?
Who Should Choose LL-37?
Choose LL-37 if you:
- Have an active chronic infection (Lyme, SIBO, biofilm-forming bacteria)
- Need direct antimicrobial and antiviral action at the infection site
- Are researching wound infections or antimicrobial-resistant bacteria
- Want a peptide that also modulates LPS-induced inflammation
Who Should Choose Thymosin Alpha-1?
Choose Thymosin Alpha-1 if you:
- Have an underactive or dysregulated immune system
- Are recovering from chemotherapy or immunosuppression
- Want to improve vaccine efficacy or T-cell function
- Are researching autoimmune modulation or viral clearance (Hepatitis B/C, COVID)
Can you stack LL-37 + Thymosin Alpha-1?
Synergistic combination. LL-37 directly targets and destroys the pathogen; Thymosin Alpha-1 enhances the adaptive immune response to finish the job and prevent recurrence. This combination is used in integrative medicine for stubborn chronic infections.
Vendor Pricing
· Affiliate links · Prices verified 2026LL-37
1 vendorAffiliate disclosure: PeptiDex may earn a commission from purchases via vendor links at no extra cost to you. See our methodology.
Frequently Asked Questions
LL-37 has broad-spectrum antimicrobial activity and can disrupt beneficial bacteria if overused or misapplied. For systemic subcutaneous use at research doses, disruption of the gut microbiome is minimal as it does not reach the gut lumen at therapeutic concentrations.
Deep Dive Profiles
Research Tools
Research Use Only — Not Medical Advice
This comparison is provided for educational and research purposes only. It does not constitute medical, prescribing, or treatment advice. Clinical data cited here is sourced from published peer-reviewed trials and FDA labels. Consult a qualified healthcare professional before making any decisions about medications or research compounds. PeptiDex is an informational resource and does not sell pharmaceutical products.